Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

Hepatitis C is of concern both to industrialized and developing countries. Preliminary
unpublished estimates of the global burden of disease (GBD) attributable to HCV‐related …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

Background With recent improvements in vaccines and treatments against viral hepatitis, an
improved understanding of the burden of viral hepatitis is needed to inform global …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Hepatitis C viral infection is endemic in Egypt with the highest prevalence rate in the world. It
is widely accepted that the implementation of mass population antischistosomal treatment …

The hepatitis C virus (HCV) is a small enveloped RNA virus belonging to the family
flaviviridae and genus hepacivirus. The HCV RNA genome is 9,600 nucleotides in length …

We are entering an important new chapter in the story of hepatitis C virus (HCV) infection.
There are clear challenges and opportunities. On the one hand, new HCV infections are still …

Purpose: To review information on the use of laboratory tests in screening, diagnosis, and
monitoring of acute and chronic hepatic injury. Data Sources and Study Selection: A …